Reconsidering S100B: Why it is time to abandon its use in detecting disease recurrence in stage III melanoma patients

M R Jansen, S Caini, I Stanganelli, L B Been, B L van Leeuwen*

*Corresponding author voor dit werk

Onderzoeksoutput: ArticleAcademicpeer review

3 Citaten (Scopus)
121 Downloads (Pure)

Vingerafdruk

Duik in de onderzoeksthema's van 'Reconsidering S100B: Why it is time to abandon its use in detecting disease recurrence in stage III melanoma patients'. Samen vormen ze een unieke vingerafdruk.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Keyphrases